This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Wright Medical Names New CEO

Wright Medical Group (WMGI - Get Report), best known for its replacement hips, now has a replacement CEO.

The orthopedics firm Monday announced that 53-year-old Laurence Fairey will become president and CEO on July 1 and retain the seat on Wright's board that he's held since January. Barry Bays, Wright's first CEO and president, will become the company's executive chairman, leaving the post he assumed in January 2000.

Shares of Wright dropped 54 cents, or 1.5%, to $35.37.

"I look forward to my new responsibilities as executive chairman of the board of directors," said Bays, 57, in a statement. "This new role will allow me to continue my direct involvement in the business and contribute to the strategy and direction of Wright, while reducing my overall time commitment."

In addition to keeping the experienced Bays on hand, Wright gains another experienced CEO with the addition of Fairey, who has 27 years of service in the orthopedics industry. From 1990 until his retirement in 2000, Fairey served a variety of executive positions, including CFO, at Medtronic Sofamor Danek and its predecessor company, Sofamor Danek Group. Before Sofamor, Fairey spent 18 years at Smith & Nephew Richards, formerly the Richards Medical company, where Bays also got his start.

"While I am taking the reigns as CEO and look forward to my new leadership role, the core executive team remains unchanged," said Fairey. "Working together with Barry and the rest of the management team, I am confident in achieving our growth objectives and financial milestones while continuing to build the company's product portfolio."

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs